InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: BlackDoggie post# 16142

Friday, 07/21/2017 1:37:23 PM

Friday, July 21, 2017 1:37:23 PM

Post# of 232948
I agree with your thoughts and think the FDA should consider allowing a broader label for both Ibalizumab and PRO 140. I was surprised they did not adjust the terms of the CYDY combo trial protocol to allow that when it was requested. So there must be a good medical reason that we don't understand yet that caused the FDA to force CYDY to stick with the triple class resistance instead of going for just double or even single.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News